Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.
Over the last 12 months, insiders at Zoetis Inc. have bought $0 and sold $11.93M worth of Zoetis Inc. stock.
On average, over the past 5 years, insiders at Zoetis Inc. have bought $2.5M and sold $85.76M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 15,180 shares for transaction amount of $2.5M was made by SCULLY ROBERT W (director) on 2021‑02‑19.
2024-04-18 | Sale | Lagano Roxanne | Executive Vice President | 923 0.0002% | $151.17 | $139,530 | +11.00% | |
2024-03-18 | Sale | Lagano Roxanne | Executive Vice President | 923 0.0002% | $173.33 | $159,984 | -1.39% | |
2024-03-11 | Sale | Reed Willie M | director | 1,370 0.0003% | $182.68 | $250,265 | -7.97% | |
2024-02-20 | Sale | PECK KRISTIN C | Chief Executive Officer | 13,000 0.0028% | $187.20 | $2.43M | -8.83% | |
2024-02-20 | Sale | Lagano Roxanne | Executive Vice President | 923 0.0002% | $187.30 | $172,878 | -8.83% | |
2024-02-13 | Sale | Lagano Roxanne | Executive Vice President | 2,848 0.0006% | $186.86 | $532,177 | -6.98% | |
2024-02-12 | Sale | Lagano Roxanne | Executive Vice President | 363 <0.0001% | $197.74 | $71,780 | -13.19% | |
2024-01-18 | Sale | Lagano Roxanne | Executive Vice President | 923 0.0002% | $191.43 | $176,690 | -9.96% | |
2023-12-18 | Sale | Lagano Roxanne | Executive Vice President | 923 0.0002% | $198.14 | $182,883 | -11.35% | |
2023-12-14 | Sale | Lagano Roxanne | Executive Vice President | 2,500 0.0005% | $200.00 | $500,000 | -11.91% | |
2023-11-21 | Sale | PECK KRISTIN C | Chief Executive Officer | 13,000 0.0028% | $176.84 | $2.3M | -0.40% | |
2023-11-17 | Sale | Lagano Roxanne | Executive Vice President | 923 0.0002% | $177.46 | $163,796 | +2.20% | |
2023-10-18 | Sale | Lagano Roxanne | Executive Vice President | 923 0.0002% | $172.92 | $159,605 | +3.13% | |
2023-09-18 | Sale | Lagano Roxanne | Executive Vice President | 923 0.0002% | $179.58 | $165,752 | -2.76% | |
2023-09-15 | Sale | Chen Heidi C. | Executive Vice President | 9,905 0.0022% | $180.15 | $1.78M | -3.04% | |
2023-09-01 | Sale | Lagano Roxanne | Executive Vice President | 923 0.0002% | $192.97 | $178,111 | -8.70% | |
2023-08-22 | Sale | PECK KRISTIN C | Chief Executive Officer | 13,000 0.0028% | $179.97 | $2.34M | -3.10% | |
2023-08-09 | Sale | Polzer Robert J | Executive Vice President | 1,179 0.0003% | $189.94 | $223,939 | -6.66% | |
2023-05-23 | Sale | PECK KRISTIN C | Chief Executive Officer | 13,000 0.0029% | $176.56 | $2.3M | +2.02% | |
2023-04-18 | Sale | Lagano Roxanne | Executive Vice President | 4,338 0.0009% | $175.94 | $763,228 | +2.93% |
PECK KRISTIN C | Chief Executive Officer | 79366 0.0124% | $170.90 | 0 | 24 | |
Chen Heidi C. | Executive Vice President | 27478 0.006% | $170.90 | 1 | 27 | +3.04% |
Lagano Roxanne | Executive Vice President | 14800 0.0038% | $170.90 | 1 | 39 | +3.04% |
Reed Willie M | 9994 0.0015% | $170.90 | 0 | 6 | ||
Polzer Robert J | Executive Vice President | 2353 0.0005% | $170.90 | 0 | 2 | |
Pershing Square Capital Management, L.P. | director | 24973145 5.4394% | $170.90 | 1 | 2 | <0.0001% |
Alaix Juan Ramon | director | 214307 0.0467% | $170.90 | 0 | 12 | |
David Glenn | Executive Vice President | 46572 0.0101% | $170.90 | 0 | 7 | |
Knupp Catherine A. | Executive Vice President | 43642 0.0095% | $170.90 | 1 | 8 | +3.04% |
Lewis Clinton A. Jr. | Executive Vice President | 27904 0.0061% | $170.90 | 1 | 12 | +3.04% |
Fenton Andrew | Executive Vice President | 21530 0.0047% | $170.90 | 0 | 2 | |
MCCALLISTER MICHAEL B | director | 9000 0.002% | $170.90 | 2 | 0 | +3% |
Trawicki Roman | Executive Vice President | 8218 0.0018% | $170.90 | 0 | 16 | |
Kelly Robert Edward | Executive Vice President | 8300 0.0018% | $170.90 | 0 | 4 | |
SCULLY ROBERT W | director | 7590 0.0017% | $170.90 | 1 | 0 | +24.75% |
Bernal Alejandro | Executive Vice President | 6310 0.0014% | $170.90 | 0 | 3 | |
Germano Geno J | director | 5000 0.0011% | $170.90 | 1 | 0 | +3.04% |
HILL CHARLES H | director | 5000 0.0011% | $170.90 | 1 | 0 | +3.04% |
SCHULMAN AMY W | director | 5000 0.0011% | $170.90 | 1 | 0 | +3.04% |
DAMELIO FRANK A | director | 5000 0.0011% | $170.90 | 1 | 0 | +3.04% |
Giordano Douglas E. | director | 5000 0.0011% | $170.90 | 1 | 0 | +3.04% |
STEERE WILLIAM C JR | director | 4500 0.001% | $170.90 | 1 | 0 | +3.04% |
Norden Gregory | director | 3899 0.0008% | $170.90 | 1 | 1 | +3.04% |
Sanjay Khosla | director | 2568 0.0006% | $170.90 | 2 | 1 | +13.24% |
Lee Joyce J. | Executive Vice President | 2000 0.0004% | $170.90 | 1 | 0 | +3.04% |
Beaty Sandra J. | Executive Vice President | 2000 0.0004% | $170.90 | 1 | 0 | +3.04% |
Rhodes Linda | director | 1468 0.0003% | $170.90 | 0 | 1 | |
Weiskopf Stefan | Executive Vice President | 320 0.0001% | $170.90 | 1 | 0 | +3.12% |
The Vanguard Group | $6.9B | 8.93 | 40.75M | +1.03% | +$70.16M | 0.13 | |
BlackRock | $6.22B | 8.05 | 36.73M | +0.65% | +$40.19M | 0.14 | |
State Street | $3.31B | 4.29 | 19.57M | +1.28% | +$41.93M | 0.14 | |
State Farm | $2.73B | 3.54 | 16.15M | -1.18% | -$32.69M | 2.46 | |
Bank of America | $2.36B | 3.06 | 13.96M | +3.39% | +$77.38M | 0.23 | |
Morgan Stanley | $2.18B | 2.82 | 12.88M | +4.58% | +$95.56M | 0.17 | |
AllianceBernstein | $2.1B | 2.72 | 12.41M | -1.3% | -$27.57M | 0.74 | |
Geode Capital Management | $1.7B | 2.2 | 10.05M | +2.07% | +$34.33M | 0.15 | |
T. Rowe Price | $1.59B | 2.05 | 9.37M | -31.67% | -$735.15M | 0.2 | |
Wellington Management Company | $1.57B | 2.03 | 9.25M | +2.64% | +$40.27M | 0.27 | |
Fidelity Investments | $1.26B | 1.63 | 7.45M | -5.96% | -$79.82M | 0.08 | |
Polen Capital | $1.19B | 1.54 | 7.01M | +40.9% | +$344.07M | 2.74 | |
Capital World Investors | $1.06B | 1.38 | 6.29M | -30.58% | -$469.02M | 0.18 | |
Wells Fargo | $1.03B | 1.33 | 6.06M | +133.63% | +$586.98M | 0.27 | |
Northern Trust | $995.49M | 1.29 | 5.88M | -0.79% | -$7.91M | 0.17 | |
Nuveen | $844.87M | 1.09 | 4.99M | -23.71% | -$262.62M | 0.25 | |
BNY Mellon | $763.07M | 0.99 | 4.51M | +3.48% | +$25.67M | 0.15 | |
Ameriprise Financial | $711.89M | 0.93 | 4.22M | +41.92% | +$210.27M | 0.2 | |
Legal & General | $705.82M | 0.91 | 4.17M | -0.86% | -$6.15M | 0.17 | |
Capital Research Global Investors | $685.42M | 0.89 | 4.05M | +2.28% | +$15.28M | 0.16 | |
Goldman Sachs | $589.98M | 0.76 | 3.49M | -22.4% | -$170.28M | 0.11 | |
Charles Schwab | $561.13M | 0.73 | 3.34M | +0.46% | +$2.57M | 0.13 | |
Royal Bank of Canada | $520.63M | 0.67 | 3.08M | +1.92% | +$9.82M | 0.12 | |
Neuberger Berman | $490.17M | 0.64 | 2.9M | +0.37% | +$1.82M | 0.41 | |
ClearBridge Investments | $486.96M | 0.63 | 2.88M | -0.06% | -$269,720.73 | 0.39 | |
LAZARD ASSET MANAGEMENT LLC | $469.2M | 0.61 | 2.77M | -2.71% | -$13.09M | 0.62 | |
Ubs Asset Management Americas Inc | $463.82M | 0.6 | 2.74M | -1.74% | -$8.23M | 0.17 | |
Dz Bank Ag Deutsche Zentral Genossenschafts Bank Frankfurt Am Main | $458.79M | 0.59 | 2.71M | +18.05% | +$70.14M | 0.52 | |
JPMorgan Chase | $446.01M | 0.58 | 2.64M | +10.84% | +$43.61M | 0.04 | |
Banque Pictet Cie Sa | $422.01M | 0.55 | 2.49M | +0.42% | +$1.77M | 4.43 | |
Blair William Co Il | $411.69M | 0.53 | 2.43M | -1.23% | -$5.13M | 1.3 | |
Amundi | $334.62M | 0.48 | 2.19M | +5.66% | +$17.91M | 0.14 | |
Qube Research & Technologies | $351.12M | 0.46 | 2.08M | +388.86% | +$279.3M | 0.43 | |
Brown Brothers Harriman Co | $350.18M | 0.45 | 2.07M | -1.57% | -$5.57M | 2.66 | |
Janus Henderson | $350.05M | 0.45 | 2.07M | -20.69% | -$91.34M | 0.19 | |
Envestnet Asset Management Inc | $345.49M | 0.45 | 2.04M | +29.23% | +$78.15M | 0.14 | |
Ci Private Wealth Llc | $331.78M | 0.43 | 1.96M | +0.37% | +$1.22M | 0.14 | |
Dimensional Fund Advisors | $316.7M | 0.41 | 1.87M | +5.94% | +$17.76M | 0.09 | |
Luther King Capital Management | $308.88M | 0.4 | 1.83M | -4.99% | -$16.22M | 1.4 | |
Deutsche Bank | $308M | 0.4 | 1.82M | -7.68% | -$25.64M | 0.14 | |
Citadel Advisors LLC | $301.12M | 0.39 | 1.78M | +2,745.84% | +$290.54M | 0.2 | |
AKO Capital LLP | $293.6M | 0.38 | 1.74M | +41.42% | +$86M | 4.16 | |
Brown Advisory | $282.63M | 0.37 | 1.67M | -9.81% | -$30.73M | 0.38 | |
Invesco | $273.21M | 0.35 | 1.61M | -37.74% | -$165.58M | 0.06 | |
Td Asset Management Inc | $268.27M | 0.35 | 1.59M | +25.86% | +$55.11M | 0.23 | |
CalPERS | $266.46M | 0.35 | 1.57M | -5.9% | -$16.7M | 0.19 | |
Jensen Investment Management | $265.72M | 0.34 | 1.57M | New | +$265.72M | 2.03 | |
D. E. Shaw & Co. | $238.68M | 0.31 | 1.41M | +19,374.87% | +$237.46M | 0.32 | |
Cibc Private Wealth Group Llc | $235.13M | 0.31 | 1.41M | -2.82% | -$6.83M | 0.47 | |
Barclays | $237.49M | 0.31 | 1.4M | +38.93% | +$66.55M | 0.11 |